Trait: endometrial cancer

Trait Information
Identifier MONDO_0011962
Description Primary or metastatic malignant neoplasm involving the endometrium (mucous membrane that lines the endometrial cavity). [NCIT: C27815]
Trait category
Cancer
Synonyms 15 synonyms
  • cancer of endometrium
  • endometrial Ca
  • endometrial cancer
  • endometrial cancer, familial, autosomal dominant, somatic mutation
  • endometrial cancer, susceptibility to, autosomal dominant, somatic mutation
  • endometrial carcinoma, somatic
  • endometrial neoplasm
  • endometrium cancer
  • malignant endometrial neoplasm
  • malignant endometrium neoplasm
  • malignant neoplasm of endometrium
  • neoplasm of endometrium
  • primary malignant neoplasm of endometrium
  • tumor of endometrium
  • tumour of endometrium
Mapped terms 4 mapped terms
  • DOID:1380
  • EFO:0004230
  • NCIT:C27815
  • OMIM:608089
Child trait(s) endometrial carcinoma

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported
Note: This table shows all PGS for "endometrial cancer" and any child terms of this trait in the EFO hierarchy by default.
Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution Scoring File (FTP Link)
PGS000075
(CC_Endo)
PGP000050 |
Graff RE et al. Nat Commun (2021)
Endometrial cancer endometrial carcinoma 9
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000075/ScoringFiles/PGS000075.txt.gz
PGS000786
(CC_Endo_IV)
PGP000186 |
Kachuri L et al. Nat Commun (2020)
Endometrial cancer endometrial carcinoma 9
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000786/ScoringFiles/PGS000786.txt.gz
PGS002300
(PRS19_endometrial)
PGP000328 |
Choi J et al. Int J Cancer (2020)
Endometrial cancer endometrial cancer 19
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002300/ScoringFiles/PGS002300.txt.gz
PGS002735
(PRS19)
PGP000344 |
Bafligil C et al. Genet Med (2022)
Endometrial cancer endometrial carcinoma 19
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002735/ScoringFiles/PGS002735.txt.gz
PGS002736
(PRS24)
PGP000344 |
Bafligil C et al. Genet Med (2022)
Endometrial cancer endometrial carcinoma 24
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002736/ScoringFiles/PGS002736.txt.gz
PGS002737
(PRS72)
PGP000344 |
Bafligil C et al. Genet Med (2022)
Endometrial cancer endometrial carcinoma 72
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002737/ScoringFiles/PGS002737.txt.gz
PGS003381
(best_UCEC)
PGP000413 |
Namba S et al. Cancer Res (2022)
Uterine endometrial carcinoma endometrial carcinoma 529,365
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003381/ScoringFiles/PGS003381.txt.gz
PGS004244
(PRS16_endometrium)
PGP000542 |
Kim ES et al. NPJ Precis Oncol (2023)
Endometrial cancer endometrial carcinoma 16
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004244/ScoringFiles/PGS004244.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM000195 PGS000075
(CC_Endo)
PSS000114|
European Ancestry|
221,699 individuals
PGP000050 |
Graff RE et al. Nat Commun (2021)
Reported Trait: Endometrial cancer OR: 1.19 [1.14, 1.24] Genotyping reagent kit (GERA cohort only), genotyping array (UK Biobank only), age, 10 PCs. Results from meta-analysis of GERA and UKB
PPM002041 PGS000075
(CC_Endo)
PSS001014|
European Ancestry|
212,156 individuals
PGP000186 |
Kachuri L et al. Nat Commun (2020)
|Ext.
Reported Trait: Incident endometrial cancer HR: 1.19 [1.1, 1.29] AUROC: 0.755
C-index: 0.749 (0.011)
Age at assessment, family history of cancer, genotyping array, PCs(1-15), parity ( ≥1 live birth vs. none), age at menarche, body mass index, Menopausal status (pre-menopausal vs. post-menopausal vs. unknown or hysterectomy), ever used hormone replacement therapy, oral contraceptive use (never used (0) vs. <20 years vs. ≥20 years), C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years.
PPM017170 PGS000075
(CC_Endo)
PSS010152|
European Ancestry|
494 individuals
PGP000443 |
Byrne S et al. Int J Epidemiol (2023)
|Ext.
Reported Trait: Uterine cancer HR: 1.31 [1.2, 1.44] age at baseline, sex (where relevant), assessment centre, 40 principal components of ancestries (PCs), Townsend Index, education, birth location, income, lifestyle index, additional cancer-specific covariates
PPM002057 PGS000786
(CC_Endo_IV)
PSS001014|
European Ancestry|
212,156 individuals
PGP000186 |
Kachuri L et al. Nat Commun (2020)
Reported Trait: Incident endometrial cancer HR: 1.18 [1.09, 1.27] AUROC: 0.754
C-index: 0.749 (0.011)
: 0.486 Age at assessment, family history of cancer, genotyping array, PCs(1-15), parity ( ≥1 live birth vs. none), age at menarche, body mass index, Menopausal status (pre-menopausal vs. post-menopausal vs. unknown or hysterectomy), ever used hormone replacement therapy, oral contraceptive use (never used (0) vs. <20 years vs. ≥20 years), C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years.
PPM013029 PGS002300
(PRS19_endometrial)
PSS009660|
European Ancestry|
629 individuals
PGP000328 |
Choi J et al. Int J Cancer (2020)
Reported Trait: Endometrial cancer AUROC: 0.64 [0.61, 0.67]
PPM013037 PGS002300
(PRS19_endometrial)
PSS009660|
European Ancestry|
629 individuals
PGP000328 |
Choi J et al. Int J Cancer (2020)
Reported Trait: Endometrial cancer Hazard ratio (HR top 5% vs average): 1.34 [0.96, 1.88] Age, birth cohort, genotyping array, top 10 PCs for ancestry and sex (for nonsex specific cancer only)
PPM014832 PGS002735
(PRS19)
PSS009907|
European Ancestry|
118,636 individuals
PGP000344 |
Bafligil C et al. Genet Med (2022)
Reported Trait: Risk of endometrial cancer AUROC: 0.56 [0.54, 0.57] Odds ratio (OR, third vs first tertile): 1.55 [1.37, 1.74]
PPM014835 PGS002735
(PRS19)
PSS009907|
European Ancestry|
118,636 individuals
PGP000344 |
Bafligil C et al. Genet Med (2022)
Reported Trait: Risk of endometrial cancer HR: 0.2 [0.15, 0.25] BMI
PPM014833 PGS002736
(PRS24)
PSS009907|
European Ancestry|
118,636 individuals
PGP000344 |
Bafligil C et al. Genet Med (2022)
Reported Trait: Risk of endometrial cancer AUROC: 0.53 [0.52, 0.54] Odds ratio (OR, third vs first tertile): 1.27 [1.13, 1.43]
PPM014836 PGS002736
(PRS24)
PSS009907|
European Ancestry|
118,636 individuals
PGP000344 |
Bafligil C et al. Genet Med (2022)
Reported Trait: Risk of endometrial cancer HR: 0.11 [0.07, 0.16] BMI
PPM014834 PGS002737
(PRS72)
PSS009907|
European Ancestry|
118,636 individuals
PGP000344 |
Bafligil C et al. Genet Med (2022)
Reported Trait: Risk of endometrial cancer AUROC: 0.54 [0.52, 0.55] Odds ratio (OR, third vs first tertile): 1.32 [1.17, 1.48]
PPM014837 PGS002737
(PRS72)
PSS009907|
European Ancestry|
118,636 individuals
PGP000344 |
Bafligil C et al. Genet Med (2022)
Reported Trait: Risk of endometrial cancer HR: 0.13 [0.08, 0.18] BMI
PPM016256 PGS003381
(best_UCEC)
PSS010086|
European Ancestry|
144,479 individuals
PGP000413 |
Namba S et al. Cancer Res (2022)
Reported Trait: uterine endometrial carcinoma AUROC: 0.761 : 0.11 age, top 20 genetic principal components
PPM020301 PGS004244
(PRS16_endometrium)
PSS011328|
European Ancestry|
133,830 individuals
PGP000542 |
Kim ES et al. NPJ Precis Oncol (2023)
Reported Trait: Endometrial cancer HR: 1.25 [1.14, 1.36] first 10 genetic principal components

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS009660 endometrial cancer (ICD-9 = 182 or ICD-10 = C54) 629 individuals European UKB
PSS009907
[
  • 1,676 cases
  • , 116,960 controls
]
,
0.0 % Male samples
European NR UKB
PSS011328 133,830 individuals,
0.0 % Male samples
European
(British)
UKB
PSS001014 Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases.
[
  • 643 cases
  • , 211,513 controls
]
,
0.0 % Male samples
European UKB
PSS010086 C54
[
  • 1,587 cases
  • , 142,892 controls
]
European
(British)
UKB Controls were samples without any cancer diagnosis or self-reported cancer
PSS000114 Cancer diagnoses were obtained from reigstry data in GERA, and ICD-9/10 codes mapped to ICD-O-3 codes in UK Biobank. Cancers for this phenotype were classified using the following SEER site recode(s): 27020
[
  • 2,051 cases
  • , 219,648 controls
]
,
0.0 % Male samples
European GERA, UKB
PSS010152
[
  • 35 cases
  • , 459 controls
]
,
0.0 % Male samples
European UKB